---
title: "PUTIAN COMM released its interim results, with shareholders' profit attributable to shareholders amounting to HKD 7.838 million, an increase of 52.82% year-on-year"
description: "According to the Zhitong Finance APP, PUTIAN COMM released its interim results for the six months ending June 30, 2025, with revenue of 299 million yuan (RMB, the same below), an increase of 6.44% yea"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/255176088.md"
published_at: "2025-08-29T10:27:03.000Z"
---

# PUTIAN COMM released its interim results, with shareholders' profit attributable to shareholders amounting to HKD 7.838 million, an increase of 52.82% year-on-year

> According to the Zhitong Finance APP, PUTIAN COMM released its interim results for the six months ending June 30, 2025, with revenue of 299 million yuan (RMB, the same below), an increase of 6.44% year-on-year; profit attributable to shareholders of 7.838 million yuan, an increase of 52.82% year-on-year; basic earnings per share of 0.007 yuan

According to the Zhitong Finance APP, PUTIAN COMM (01720) announced its interim results for the six months ending June 30, 2025, with revenue of 299 million yuan (RMB, the same below), an increase of 6.44% year-on-year; profit attributable to shareholders of 7.838 million yuan, an increase of 52.82% year-on-year; basic earnings per share of 0.007 yuan

### Related Stocks

- [01720.HK - PUTIAN COMM](https://longbridge.com/en/quote/01720.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CSPC Pharmaceutical Group Receives FDA Approval for SYH2082 Clinical Trial in the US | CSPC Pharmaceutical Group Ltd. has received FDA approval to conduct clinical trials for SYH2082, a GLP-1/GIP receptor du | [Link](https://longbridge.com/en/news/276033771.md) |
| Obeikan Glass Changes Its Trading Name From "Obeikan Glass" To "OGC" | OBEIKAN GLASS :OBEIKAN GLASS - CHANGES ITS TRADING NAME FROM "OBEIKAN GLASS" TO "OGC" | [Link](https://longbridge.com/en/news/276033502.md) |
| Nomura Upgrades China Literature to Buy From Neutral, Adjusts Price Target to HK$47 From HK$33 | Nomura Upgrades China Literature to Buy From Neutral, Adjusts Price Target to HK$47 From HK$33 | [Link](https://longbridge.com/en/news/275882954.md) |
| Lenovo Caught Napping By 'Democratization Of AI' | Lenovo reported a 21% profit decline in its latest fiscal quarter, taking a $285 million restructuring charge due to a s | [Link](https://longbridge.com/en/news/275904944.md) |
| Xiaomi bought back 2.7 mln class B shares for HK$98.4 mln on Feb 13, HKEX shows | Xiaomi bought back 2.7 mln class B shares for HK$98.4 mln on Feb 13, HKEX shows | [Link](https://longbridge.com/en/news/275886566.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.